Bridgewater, N.J. and Mumbai, India (May 1, 2024) — OmniActive Health Technologies (OmniActive) is proud to announce its collaboration with the Council of Responsible Nutrition (CRN) to highlight the significance of lutein and zeaxanthin isomers for prenatal nutrition at The American College of Obstetrics and Gynecology’s (ACOG) Annual Clinical & Scientific Meeting.

The partnership aims to educate and elevate awareness among obstetricians and gynecologists, and other maternal healthcare practitioners about the pivotal role of lutein and zeaxanthin in supporting maternal and fetal health during pregnancy. This initiative underscores OmniActive and CRN’s commitment to advancing the understanding of nutritional requirements during pregnancy and ensuring the availability of scientifically validated products to meet these needs.

“It’s wonderful to have OmniActive as one of our featured partners during the ACOG annual event to help spread the word on the importance of prenatal nutrition,” said Dr. Andrea Wong, Sr. Vice President, Scientific & Regulatory Affairs, Council of Responsible Nutrition. “CRN continues our efforts in supporting supplement manufacturers and ingredient suppliers in bringing clinically studied products to consumers to help meet their nutritional needs. Advancing awareness at the physician’s level is a huge part of this equation and this meeting is an effective way of reaching them.”

In the US, prenatal vitamins and supplements sales are expected to have exponential growth in the coming years, with estimates of $740M in 2023 rising to $1.43B by 2031, according to SkyQuest Technology. This growth is indicative of an increasing awareness around the importance of nutrition and supplementation during pregnancy. Moreover, a recent study showed that roughly 60% of gynecologists believe that 80-100% of their patients take supplements during pregnancy. As research around the nutritional needs in pregnancy expands, so will the need to bring products that deliver efficacious levels of certain nutrients, such as lutein and zeaxanthin, to the market.

“Current evidence supports the preferential accumulation of lutein and zeaxanthin in the human eye and neural tissues during pregnancy, especially during the third trimester. This suggest that lutein may play a functional and protective role in infant visual and cognitive development.  As part of our Lutein For Every Age campaign, our goal is to help educate healthcare practitioners on this latest nutritional science research and the benefits of achieving adequate dietary lutein during pregnancy,” said Deshanie Rai, PhD, FACN, VP of Global Science, Regulatory and Advocacy at OmniActive Health Technologies. “OmniActive is proud to partner with the CRN Foundation’s Prenatal Nutrition Centre to promote awareness among healthcare practitioners on the nutritional relevance of lutein for both mom and baby.”

“Lutein for Every Age” is an educational initiative, which focuses on raising awareness of early and consistent lutein and zeaxanthin intake to help support eye, cognitive, and general health throughout life. Through various media, digital platforms, in-person events, scientific advocacy, and key opinion leaders, OmniActive remains committed to educating consumers and healthcare practitioners on the importance of these essential nutrients.

This year’s ACOG meeting will take place on May 17-19, 2024, in San Francisco, CA and is one of the largest US events of its kind, drawing thousands of physicians and healthcare professionals. To learn more about OmniActive’s latest studies on lutein and zeaxanthin or the “Lutein for Every Age” initiative visit Lutemax.com/lfea.

About OmniActive
Established in 2005, OmniActive Health Technologies seeks to improve lives through innovative science and natural health solutions. OmniActive’s product portfolio consists of scientifically validated, IP-protected, branded Specialty Actives and an extensive portfolio of natural Botanical Actives for global customers in the dietary supplement, functional food, and beverage markets. The company has offices in Mumbai, India, and Bridgewater, New Jersey.